Ms. Sherman assumed the CEO role for Kovina Therapeutics in April 2021. Prior to joining Kovina, she served as the Chief Operating Officer for VMS BioMarketing, a healthcare marketing firm focused on improving patient outcomes for pharma and biotech clients.  Her prior experience includes serving as the Chief Financial Officer for private biotech companies such as Calibrium, LLC until its acquisition by Novo Nordisk in 2015 and Marcadia Biotech which was purchased by Roche in 2010.  Ms. Sherman also worked as the Vice President and Treasurer for Guidant Corporation during the sale of Guidant to Abbott and Boston Scientific and previously served as Guidant’s first financial director for the emerging markets region located in Belgium.  In addition, Ms. Sherman worked as Guidant’s Assistant Treasurer during the company’s spin-off from Eli Lilly and Company.  She began her career in finance and human resources with Eli Lilly and Company.  Ms. Sherman is the chair for the Community Health Network Board of Directors, the current chair of the Compensation Committee and the prior chair of the Audit, Compliance and Finance Committee. She also served as a board member and chair of the Audit Committee for Lacy Diversified Industries. Ms. Sherman earned her BA in economics from DePauw University and an MBA from The Tuck School of Business at Dartmouth.